Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02888431 · ClinicalTrials.gov registry record
Correlation of Arterial and Venous Lactate and Base Deficit Values
A clinical trial, sponsored by Joseph D. Tobias.
- Completed
- Registry status
- 50
- Enrollment target
NCT02888431: Completed study, sponsored by Joseph D. Tobias.
NCT02888431 is a clinical trial that has completed, run by Joseph D. Tobias. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02888431 has completed, sponsored by Joseph D. Tobias.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the correlation between pH, base deficit, and lactate values when comparing venous and arterial blood samples in the pediatric population.
Primary Outcome
blood will be drawn from peripheral venous line, arterial line, and/or central venous line then the lactate value will be assessed by using a bedside point-of-care device, called i-stat.
Interventions
- DEVICE bedside point-of-care device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-12 |
What the finished NCT02888431 record still lists
NCT02888431 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which bedside point-of-care device is the first listed.
NCT02888431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02888431 about?
NCT02888431 is a clinical study titled "Correlation of Arterial and Venous Lactate and Base Deficit Values". The purpose of this study is to determine the correlation between pH, base deficit, and lactate values when comparing venous and arterial blood samples in the pediatric population.
What is the current status of trial NCT02888431?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2015-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02888431?
The interventions under investigation include: bedside point-of-care device (DEVICE).
Who is sponsoring clinical trial NCT02888431?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia